This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

US FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs: Maryland Tuesday, April 15, 2025, 14:00 Hrs [IST] The US Food and Drug Adm ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The team created a novel tick antigen library housing over 3,000 different proteins, testing each to create a target cocktail ...